Nobel Laureate, Professor of Biology, Caltech
Professor, Michigan State University
Vice president, chief strategy and operating officer of the Texas Medical Center
Managing Director of Hatteras Discovery and Venture Partner at Hatteras Venture Partners
Russia represents the next frontier for the pharmaceutical industry. Biocom has organized this session to provide an overview of the pharma, diagnostics, and medical device development in Russia, along with market access and opportunities for global partnerships. Speakers will review the growth potential, challenges and risk profile of the rapidly expanding Russian pharmaceutical industry; new partnership opportunities and the exploration of national initiatives such as Pharma2020 and MedProm2020. More information and online registration is here.